Biotechnology in drug delivery represents a revolutionary field that harnesses biological processes and techniques to enhance the targeted and efficient delivery of pharmaceutical compounds. This cutting-edge approach seeks to overcome traditional challenges in drug delivery, such as limited specificity and potential side effects. Through the integration of biotechnological tools, researchers can design advanced drug delivery systems that optimize therapeutic outcomes while minimizing adverse effects. One key aspect of biotechnology in drug delivery involves the development of innovative drug carriers, often utilizing biomaterials or nanoparticles. These carriers can be engineered to encapsulate drugs, protecting them from degradation and facilitating their release at specific sites within the body. Furthermore, biotechnological advancements enable the customization of drug delivery systems based on the unique characteristics of diseases or individual patients. Biotechnology also plays a crucial role in designing drug formulations that respond dynamically to physiological changes. Smart drug delivery systems, guided by biological signals, allow for on-demand release of therapeutic agents, maximizing efficacy while minimizing systemic exposure. This level of precision is particularly valuable in the treatment of complex diseases, including cancers and chronic conditions. Moreover, biotechnological interventions contribute to the development of personalized medicine approaches. By leveraging genetic information and molecular targeting, drug delivery systems can be tailored to the genetic makeup of patients, increasing treatment effectiveness and reducing the risk of adverse reactions. In conclusion, biotechnology in drug delivery is revolutionizing the pharmaceutical landscape by offering solutions that enhance drug efficacy, minimize side effects, and pave the way for personalized therapeutic interventions. As this field continues to evolve, it holds the promise of transforming the way we approach and administer treatments, ultimately improving patient outcomes and quality of life.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Phage Display-Based Biosensing for Rapid Detection of Neonatal Group B Streptococcal (GBS) Infection
Md Monir Hossain, RMIT University, Australia
Title : Contribution of bioengineered food in addressing hunger and food and nutrition security (FNS)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : An insight into sustainable practices in Environmental Biotechnology (EB)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India